Russian Federation: Tightening Control Over Prices For Crucial Medicines

Last Updated: 24 June 2015
Article by Anna McDonald

Governmental regulation of vital and essential medicines (hereinafter Essential Drugs) in the Russian Federation in the form in which it exists today has been functioning since 2010. The list of Essential Drugs (“EDL List”) has already been updated several times but the essence of regulation remains the same.

Subject to restriction is the maximum price for EDL Drugs. This price must be calculated by determining (and registering) the manufacturer's sales price and applying wholesale and retail markups that are set by the Russian Federation constituent entities. Dealing in EDL durgs imposes additional obligations on all participants in the distribution chain from the manufacturer to the retail seller, starting with compliance with the pricing procedure and ending with the need to prepare additional documentation such as, for example, a price negotiation protocol.

The local divisions of a number of state authorities may audit a retail seller's compliance with pricing rules for EDL drugs:

  • the Federal Healthcare Supervisory Service ("Roszdravnadzor");
  • the Prosecutor's Office;
  • the Federal Antimonopoly Service ("FAS") (if the audit is of a dominant entity or otherwise related to the antimonopoly legislation);
  • other competent authorities of the RF constituent entity, such as various tariff and pricing policy committees, consumer social protection departments, etc.

Liability for overcharging for EDL drugs arises under Article 14.6 (Violation of Pricing Procedure) of the Russian Federation Code on Administrative Offenses (for legal entities the penalty is double the extra proceeds from the sale of an EDL drug over the registered  prices for such EDL drug for the entire period during which the offense was committed, but not more than one year).

Since its introduction, regional regulation of EDL drugs has led to differences in the degree and measures for exercising control in various constituent entities of the Russian Federation. Audits may be conducted both during general audits of compliance with the law and licensing requirements, as well as in response to consumer complaints. Individual audits at a specific entity or at a specific pharmacy are interspersed with mass audits. For example, recently the Prosecutor's Office initiated mass audits of retail prices for EDL drugs in Moscow.[1]

Prices for many pharmaceuticals (including EDL drugs) started to actively go up at the end of 2014 with the fall of the ruble exchange rate. This led to a growing number of complaints both from end consumers and from wholesale distributors. The number of audits also increased. For example, as early as February 26, 2015 the FAS sent an order calling to tighten control over pricing of dominant entities at the regional retail markets for pharmaceuticals, medical devices and associated goods. According to the comments of their representatives, many FAS departments [2] renewed monitoring of prices for EDL drugs. In April 2015 the General Prosecutor's Office and the FAS received an appeal from the Audit Chamber calling on them to check into the rise in medicine prices.

The numerous audits yielded results. As at the end of April 2015 the Prosecutor's Office had opened 779 administrative offense cases in 2015 for exceeding the permitted markups on EDL drugs [3].  On May 18, 2015 the FAS published information [4] that, according to the results of audits, 14 administrative investigations were initiated in a number of constituent entities based upon the evidence of overstated prices of EDL drugs. Regional regulation is also getting tighter. For example, Moscow Government Resolution No. 134-PP of March 24, 2015 gave the Moscow Department of Health the right to initiate and resolve administrative offense cases related to pricing of EDL drugs (prior to that time the Health Department had the authority to conduct audits and issue directives, but was not entitled to initiate the relevant cases on its own).

RF Government Decree No. 434 "On Regional State Control over the Application of Prices for Medicines on the List of Crucial Medicines" (the Decree) was enacted on May 6, 2015. According to the Decree, the relevant competent executive authorities of Russian Federation constituent entities (primarily the Roszdravnadzor authorities) monitor prices of EDL drugs by:

  • organizing and conducting audits of the monitored entity's compliance with mandatory requirements;
  • systematically observing the performance of mandatory requirements by a monitored entity; taking steps, according to the procedure of Russian Federation law, to stop discovered violations of
  • mandatory requirements and/or remedy the consequences of such violations, issue directives to remedy discovered violations of mandatory requirements and take steps to prosecute the offenders.

Comments of experts and representatives of Roszdravnadzor on the Decree differ. For example, adviser to the head of Roszdravnadzor Olga Maleeva asserts that [5] the Decree merely specifies powers that already belonged to the regional authorities. Other specialists and representatives of Roszdravnadzor assert that the Resolution formally establishes the right to conduct audits that are specifically oriented toward pricing of EDL drugs.

Amendments are already being made to regional acts to reflect in them the principles stipulated in the Decree. For example, the Administrative Regulations for the Moscow Department of Health to perform the state function of regional state control over the application of prices of medicines on the EDL list (approved by the Moscow Government Resolution of November 18, 2014) have amended the previous Moscow City Government Resolution No. 320-PP of June 4, 2015. For one thing, a new method of controlling prices for EDL Drugs has been set up: systematic observation that does not require interaction with the entities being monitored. Observation is by "visual review" of information on the pharmaceutical entity's website. This is done at least once a month and the results are taken into consideration when the audit plans are being drawn up.  The authorities are not permitted to request any documents or information from pharmaceutical entities when performing such systematic observation.

Active audits of prices for EDL drugs—primarily retail prices—are expected to continue.


[2] / 

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Mondaq Advice Centre (MACs)
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.